However, more careful studies both by Tremblay and coworkers and by our group revealed that GPR39 deficiency is associated with β-cell dysfunction including decreased expression of key regulatory genes and impaired glucose-induced insulin secretion, for example from isolated perifused pancreatic islets as well as moderate glucose intolerance in vivo [16, 17]. The gene discussed is GPR39; the disease is Glucose intolerance.